Home » Trials » SLCTR/2024/021


Open-Label, Randomized Controlled Trial to Investigate Physiotherapist and Occupational Therapist Delivered Pain Coping Skills Psychological Intervention Versus Standard Care in Relieving Pain and Psychological Distress in Sinhala-conversant Patients with Chronic Knee Osteoarthritis

-

SLCTR Registration Number

SLCTR/2024/021


Date of Registration

17 Jun 2024

The date of last modification

Jun 17, 2024



Application Summary


Scientific Title of Trial

Open-Label, Randomized Controlled Trial to Investigate Physiotherapist and Occupational Therapist Delivered Pain Coping Skills Psychological Intervention Versus Standard Care in Relieving Pain and Psychological Distress in Sinhala-conversant Patients with Chronic Knee Osteoarthritis


Public Title of Trial

Open-Label, Randomized Controlled Trial to Investigate Physiotherapist and Occupational Therapist Delivered Pain Coping Skills Psychological Intervention Versus Standard Care in Relieving Pain and Psychological Distress in Sinhala-conversant Patients with Chronic Knee Osteoarthritis


Disease or Health Condition(s) Studied

Chronic knee osteoarthritis


Scientific Acronym

None


Public Acronym

None


Brief title

None


Universal Trial Number

U1111-1307-4095


Any other number(s) assigned to the trial and issuing authority

EC-24-015


Trial Details


What is the research question being addressed?

Does a pain coping skills psychological intervention delivered by physiotherapists and occupational therapists offer greater relief from pain and psychological distress (Depression, Anxiety and Stress) compared to standard care in Sinhala-conversant patients with chronic knee osteoarthritis?


Type of study

Interventional


Study design

Allocation

Randomized controlled trial


Masking

Masking not used


Control

Standard therapy/practice


Assignment

Other


Purpose

Supportive care


Study Phase

Not Applicable


Intervention(s) planned

Study setting: Department of Rheumatology and Rehabilitation (special unit) at the National Hospital of Sri Lanka (NHSL), Colombo and Clinical Medicine and Research Centre (ClinMARC), NHSL.

The pain coping skills group intervention (PCSGI) involves six-weekly (one per week) group sessions, approximately 50-60 minutes each, delivered by a either occupational therapists (OT) or physiotherapists (PT) who are trained by a licensed clinical psychologist one to one. The PCSGI therapist manual provides a session-by-session plan for a cognitive behaviour therapy-based psychological intervention. Participants are provided with handouts to facilitate each session, along with an audio recording to guide relaxation techniques.

Session title, tasks and skills learned in each session, and time duration for each task of the pain coping skills intervention.

Week 01 :Pre-group planning and orientation to the pain coping skills intervention
Chronic pain education - provide a brief overview of the cognitive behavior chronic pain model Goal setting and homework
Obtaining participants feedback and answer their questions (Q & A session)

Week 02 Relaxation techniques
Discuss week 1 homework
Pre-preparation instructions for relaxation techniques Discuss benefits of relaxation
Practicing relaxation techniques
Homework, Q & A session

Week 03 Exercise and Pacing; pleasant activity scheduling Discuss week 2 homework
Education on pacing and over activity cycle
Exploring pleasant activities Learning on benefits of pleasant activities
Preparing a pleasant activity schedule
Homework, Q & A session

Week 04 Identify Negative Automatic Thoughts
Discuss week 3 homework
Teaching relationship between thoughts, emotions and chronic pain
Training on identifying negative automatic thoughts (provide examples)
Homework, Q & A session

Week 05 Cognitive coping and calming self-statements
Discuss week 4 homework
Challenging negative automatic thoughts
Learning self-statements
Homework, Q & A session
Early preparation for the termination

Week 06 Termination of Pain Coping Skills Intervention
Discuss week 5 homework
Review of progress
Education on coping with flare-ups
Termination, Q & A session

The Q & A session will be a brief 5 to 10-minute discussion between patients and the PT/OT regarding the session they conducted.

Randomization and Group Allocation: Patients will be randomly assigned into one of three groups using a computer-generated random number table with a 1:1:1 allocation ratio:

Group 1 - PT Delivered PCSGI This group will receive PCSGI by PT alongside standard Treatment as Usual (TAU).

Group 2 – OT Delivered PCSGI This group will receive PCSGI by OT alongside standard Treatment as Usual.

Group 3 - Waitlist Control Group This group will receive standard TAU only. Once the trial is over, they will be offered the PCSGI.

Standard Treatment as Usual (TAU): TAU includes pharmacological treatments, physiotherapy, occupational therapy, and other medical treatments by the consultant rheumatologist and clinic staff. The principal investigator will not influence TAU.


Inclusion criteria

i. Males and Females with an age greater than or equal to 50 years ii. Diagnosis of knee osteoarthritis, verified by the consultant rheumatologist, adhering to criteria established by the American College of Rheumatology (presence of crepitus and morning stiffness lasting more than 30 minutes, accompanied by bony enlargement; or presence of crepitus and morning stiffness lasting 30 minutes or less; or absence of crepitus and presence of bony enlargement). [Note: As the principal investigator's expertise lies in clinical psychology, diagnosis confirmation for study recruitment will be conducted by a Consultant Rheumatologist (co-investigator). iii. Knee pain for greater than or equal to three months (IASP Task Force on Taxonomy, 1994) iv. Overall average knee pain in the last week of greater than 40 on a 100 mm Visual Analogue Scale [Note: Stratified sampling by pain severity will be incorporated during participant recruitment to ensure baseline comparability of pain severity among the three study groups]. v. Participants must be conversant in Sinhala and confirm their ability to read, write, and understand the Sinhala language. This is essential for completing study measures and comprehending the delivered through the intervention sessions, which will be conducted in Sinhala. vi. Participants must have access to a telephone or mobile phone to receive reminders related to session attendance and follow-up assessments vii. Participants must possess the ability to read and write, understand, and follow given instructions, equivalent to junior secondary education in Sri Lanka (grade 9 or lower in local and international education syllabus).


Exclusion criteria

i. Knee surgery including arthroscopy within the past 6 months ii. Awaiting or planning any back or lower limb surgery within the next 12 months iii. Current or past (within 3 months) oral or intra-articular corticosteroid use iv. Systemic arthritis conditions such as rheumatoid arthritis v. Participation in a psychologically based training program for pain coping abilities within the previous two years vi. Identified mild cognitive impairment using the Montreal Cognitive Assessment-Sinhala version test score of less than 26 vii. Have received a confirmed diagnosis of a mental illness and any underlying neurological issues from a consultant psychiatrist or a neurologist. However, patients with mild, unrelated neurological issues, such as carpal tunnel syndrome, are not excluded viii. Patients with cancer pain ix. Utilizing alternative therapy modalities such as Ayurveda medicine, native medicine, homeopathic medication, acupuncture treatment, or exercises designed specifically for the knee learned from non- professional sources, such as family, friends, or online videos over the past six months and currently.



Primary outcome(s)

1.

The Visual Analogue Scale (VAS) - change in mean pain intensity scores from baseline to post-intervention and follow-up assessments.

[

The primary outcomes will be measured at 3-time points: Baseline (before the commencement of the intervention), post-intervention (just after termination of the six sessions of the intervention) and follow-up (after 3-months of the termination of the intervention)

]
2.

The Depression, Anxiety and Stress Scale (DASS-21) - changes in mean depression, anxiety, and stress levels by calculating the difference in total scores between baseline and post-intervention/follow-up assessments.

[

The primary outcomes will be measured at 3-time points: Baseline (before the commencement of the intervention), post-intervention (just after termination of the six sessions of the intervention) and follow-up (after 3-months of the termination of the intervention)

]

Secondary outcome(s)

1.

The Coping Strategies Questionnaire (CSQ) - change in mean scores from baseline to post-intervention/follow-up assessments.

[

The secondary outcomes will be measured at 3-time points: Baseline (before the commencement of the intervention), post-intervention (just after termination of the six sessions of the intervention) and follow-up (after 3-months of the termination of the intervention)

]
2.

The World Health Organization Quality of Life Questionnaire (WHOQOL-BREF) - changes in mean scores from baseline to post-intervention/follow-up assessments

[

The secondary outcomes will be measured at 3-time points: Baseline (before the commencement of the intervention), post-intervention (just after termination of the six sessions of the intervention) and follow-up (after 3-months of the termination of the intervention)

]

Target number/sample size

64 (21 in each arm, 3 arms)


Countries of recruitment

Sri Lanka


Anticipated start date

2024-06-17


Anticipated end date

2025-01-20


Date of first enrollment


Date of study completion


Recruitment status

Pending


Funding source


Regulatory approvals



State of Ethics Review Approval


Status

Approved


Date of Approval

2024-04-18


Approval number

EC-24-015


Details of Ethics Review Committee

Name: Ethics Review Committee, Faculty of Medicine, University of Colombo
Institutional Address:Ethics Review Committee, Faculty of Medicine, University of Colombo, PO Box 271, Kynsey Road, Colombo 8, Sri Lanka.
Telephone:+94-11-2695300 ext 240
Email: ethicscommitteemfc@gmail.com

Contact & Sponsor Information


Contact person for Scientific Queries/Principal Investigator

Medhavi Gunasekara
Clinical Psychologist
Faculty of Medicine, No. 25, Kynsey Road, Colombo 08, Sri Lanka
+94 77 100 2321


medhavi.gunasekara@gmail.com

Contact Person for Public Queries

Prof. Piyanjali de Zoysa
Senior Professor, Clinical Psychologist
Faculty of Medicine, No. 25, Kynsey Road, Colombo 08, Sri Lanka
+94 112 695 300 Ext. 211


ptdz@sltnet.lk


Primary study sponsor/organization







Secondary study sponsor (If any)







Trial Completion details


Do the investigators plan to share identified individual clinical trial participant-level data (IPD)?

Yes


IPD sharing plan description

Individual participant data that underlie the results being reported will be shared after de-identification (text, tables, figures and appendices). The study protocol will also be shared. Data will be shared with investigators whose proposed use of the data has been approved by an independent review committee identified for this purpose, including for individual participant data meta-analysis. Proposals should be directed to medhavi.gunasekara@gmail.com. To gain access, data requesters will need to sign a data access agreement.


Study protocol available

No


Protocol version and date

Not Available


Protocol URL

Not Available


Results summary available

No


Date of posting results


Date of study completion


Final sample size


Date of first publication


Link to results


Brief summary of results